Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/16/2005CN1227032C Vaccines with an LTB adjuvant
11/16/2005CN1227029C Combination of hypertension converting enzyme inhibitor with a diuretic for treating microcirculation disorders
11/16/2005CN1227028C Use of gene recombination human lysozyme against drug resistant bacteria in preparation of medicine
11/16/2005CN1227027C Novel compositions
11/16/2005CN1227026C Method for using silkworm to express human interleukin 11 to produce medicine
11/16/2005CN1227025C Improved methods for processing activated protein C
11/16/2005CN1226973C Vacuum assisted closure system with provision for introduction of agent
11/15/2005US6965049 Zwitterionic lipid compound and uses thereof
11/15/2005US6965025 Antisense modulation of connective tissue growth factor expression
11/15/2005US6965024 Reactive with ganglioside GD3; cancer treatment
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6965016 Antagonist for use in the prevention of fertility in humans and animals
11/15/2005US6965014 Bioerodible film; mixture of thrombin and fibrinogen; controlling coagulation; drug delivery of antitumor, anticancer agents
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964971 Oral administering; sustained release
11/15/2005US6964950 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
11/15/2005US6964948 Therapeutic peptide-based constructs derived from Domain II of bactericidal/permeability-increasing protein
11/15/2005US6964947 Mixture of nerve growth factor and buffer
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964852 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
11/15/2005US6964849 Proteins and nucleic acids encoding same
11/15/2005US6964769 Molecular antigen array
11/15/2005US6964768 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/15/2005US6964765 Hybrid nucleic acid; isolation antibody
11/15/2005US6964764 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/15/2005US6964763 Methods and compositions for inhibiting HIV infectivity and blocking chemokine activity
11/15/2005US6964761 Administering and depositing interferon in the lungs; for patients are unresponsive to treatment with corticosteroid, cyclophosphamide, and azathioprine; therapeutic dosage pluse immunosuppressant or antiinflammatory agent; drug delivery
11/15/2005CA2311988C Crystalline oxathiolane derivatives
11/15/2005CA2280565C Cosmetic use of botulinum toxin for treatment of downturned mouth
11/15/2005CA2153787C Solution containing igf-1
11/15/2005CA2090121C Uses of colony stimulating factor-1
11/14/2005CA2467312A1 Inhibition of the trnalys3-primed initiation of reverse transcription in hiv-1 by apobec3g
11/13/2005CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
11/10/2005WO2005106493A1 Diagnostics and therapeutics for diseases associated with g protein-coupled apelin receptor (apj)
11/10/2005WO2005106490A1 Diagnostics and therapeutics for diseases associated with chemokine-like receptor 1 (cmklr1)
11/10/2005WO2005106487A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 9 (dpp9)
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005105996A1 A pax-encoding vector and use thereof
11/10/2005WO2005105995A2 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/10/2005WO2005105840A2 Cd40 variants and uses thereof
11/10/2005WO2005105837A2 Use of the ribosomal protein rpl41 to treat infections and inhibit cancer
11/10/2005WO2005105835A1 A protein involved in cancer
11/10/2005WO2005105832A2 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005WO2005105831A1 Antimicrobial polypeptides
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105828A1 Pseudopeptides growth hormone secretagogues
11/10/2005WO2005105826A1 Tyropeptin a analogue
11/10/2005WO2005105148A2 Liquid growth hormone formulation
11/10/2005WO2005105138A2 Collagen mimics
11/10/2005WO2005105137A1 Use of growth hormone in treatment of long-bone fractures
11/10/2005WO2005105136A1 Nanogene therapy for cell proliferation disorders
11/10/2005WO2005105135A1 Il-6 for therapy or prevention of chemotherapy-induced neuropathy
11/10/2005WO2005105134A1 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy
11/10/2005WO2005105133A2 Methods and compositions for preserving the viability of photoreceptor cells
11/10/2005WO2005105132A1 Methods for preventing or treating bone disorders
11/10/2005WO2005105131A1 Modulation of cartilage homeostasis
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105129A2 Epitopes related to coeliac disease
11/10/2005WO2005105121A1 Use of platelets or platelet rich plasma (prp)
11/10/2005WO2005105111A1 Artificial lung surfactant composition and method of using the same
11/10/2005WO2005105080A1 Combination therapy to treat diarrhea induced by cancer treatment
11/10/2005WO2005105064A2 Modulators of frat-lrp interaction in the treatment of bone-related diseases
11/10/2005WO2005105057A1 Sustained release formulations
11/10/2005WO2005105042A1 Buccal, polar and non-polar sprays containing propofol
11/10/2005WO2005104763A2 Improved method for identifying peptides in a biological sample
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2005084210A3 Multiplex detection probes
11/10/2005WO2005083441A3 Diagnostic and therapeutics for diseases associated with proto-oncogene tyrosine-protein kinase (fyn)
11/10/2005WO2005082397B1 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
11/10/2005WO2005077338A8 Particles for inhalation rapid release properties
11/10/2005WO2005075665A3 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
11/10/2005WO2005059719A3 Calculating confidence levels for peptide and protein identification
11/10/2005WO2005056042A3 Methods of protecting against radiation using flagellin
11/10/2005WO2005051327A3 Glycopegylated erythropoietin
11/10/2005WO2005047322A3 Factor viii compositions and methods
11/10/2005WO2005037860A3 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/10/2005WO2005025592A3 In vivo modulation of neuronal transport
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2005023328A3 Methods for intradermal delivery of therapeutics agents
11/10/2005WO2004089394A8 Treatment of severe acute respiratory syndrome (sars)
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004082634A3 Facially amphiphilic polymers and oligomers and uses thereof
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005WO2004063963A3 Novel proteins with altered immunogenicity
11/10/2005WO2004016754A3 ANTISENSE MODULATION OF Nav1.3 EXPRESSION
11/10/2005WO2003029275A3 Anti-angiogenic peptides
11/10/2005US20050251873 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/10/2005US20050250936 Modified TGF-beta superfamily proteins
11/10/2005US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization
11/10/2005US20050250933 Vaccines
11/10/2005US20050250852 For facilitating the delivery of active agents, such as insulin, to a target
11/10/2005US20050250817 Pharmaceutical compositions of lipase-containing products, in particular of pancreation
11/10/2005US20050250801 Method of treating cancer with azaspirane compositions
11/10/2005US20050250727 Use of immunomodulating agents
11/10/2005US20050250721 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure
1 ... 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 ... 3163